Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Cancer incidence in a Nationwide HIV/AIDS patient cohort in Taiwan in 1998-2009.

Chen M, Jen I, Chen YH, Lin MW, Bhatia K, Sharp GB, Law MG, Arthur Chen YM.

J Acquir Immune Defic Syndr. 2014 Apr 1;65(4):463-72. doi: 10.1097/QAI.0000000000000065.

2.

Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population in a large health district of Northern Italy, 1999-2009.

Calabresi A, Ferraresi A, Festa A, Scarcella C, Donato F, Vassallo F, Limina R, Castelli F, Quiros-Roldan E; Brescia HIV Cancer Study Group.

HIV Med. 2013 Sep;14(8):481-90. doi: 10.1111/hiv.12034. Epub 2013 Apr 7.

3.

Trends and predictors of non-AIDS-defining cancers in men and women with HIV infection: a single-institution retrospective study before and after the introduction of HAART.

Franzetti M, Adorni F, Parravicini C, Vergani B, Antinori S, Milazzo L, Galli M, Ridolfo AL.

J Acquir Immune Defic Syndr. 2013 Apr 1;62(4):414-20. doi: 10.1097/QAI.0b013e318282a189.

PMID:
23274934
4.

Burden of non-AIDS-defining and non-virus-related cancers among HIV-infected patients in the combined antiretroviral therapy era.

Albini L, Calabresi A, Gotti D, Ferraresi A, Festa A, Donato F, Magoni M, Castelli F, Quiros-Roldan E.

AIDS Res Hum Retroviruses. 2013 Aug;29(8):1097-104. doi: 10.1089/AID.2012.0321. Epub 2013 May 9.

PMID:
23581483
5.

HIV and cancer: a comparative retrospective study of Brazilian and U.S. clinical cohorts.

Castilho JL, Luz PM, Shepherd BE, Turner M, Ribeiro SR, Bebawy SS, Netto JS, McGowan CC, Veloso VG, Engels EA, Sterling TR, Grinsztejn B.

Infect Agent Cancer. 2015 Feb 2;10:4. doi: 10.1186/1750-9378-10-4. eCollection 2015.

6.

Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.

Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, Rapiti E, Levi F, Jundt G, Fisch T, Bordoni A, De Weck D, Franceschi S; Swiss HIV Cohort.

J Natl Cancer Inst. 2005 Mar 16;97(6):425-32.

PMID:
15770006
7.

Cancer, immunodeficiency and antiretroviral treatment: results from the Australian HIV Observational Database (AHOD).

Petoumenos K, van Leuwen MT, Vajdic CM, Woolley I, Chuah J, Templeton DJ, Grulich AE, Law MG; Australian HIV Observational Database.

HIV Med. 2013 Feb;14(2):77-84. doi: 10.1111/j.1468-1293.2012.01038.x. Epub 2012 Aug 30.

8.

Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the United States.

Simard EP, Pfeiffer RM, Engels EA.

Cancer. 2011 Mar 1;117(5):1089-96. doi: 10.1002/cncr.25547. Epub 2010 Oct 19.

9.

Cancer as a cause of death among people with AIDS in the United States.

Simard EP, Engels EA.

Clin Infect Dis. 2010 Oct 15;51(8):957-62. doi: 10.1086/656416.

10.

Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals.

Burgi A, Brodine S, Wegner S, Milazzo M, Wallace MR, Spooner K, Blazes DL, Agan BK, Armstrong A, Fraser S, Crum NF.

Cancer. 2005 Oct 1;104(7):1505-11.

11.

Epidemiologic contributions to recent cancer trends among HIV-infected people in the United States.

Robbins HA, Shiels MS, Pfeiffer RM, Engels EA.

AIDS. 2014 Mar 27;28(6):881-90. doi: 10.1097/QAD.0000000000000163.

12.

Cancer incidence and mortality for all causes in HIV-infected patients over a quarter century: a multicentre cohort study.

Raffetti E, Albini L, Gotti D, Segala D, Maggiolo F, di Filippo E, Saracino A, Ladisa N, Lapadula G, Fornabaio C, Castelnuovo F, Casari S, Fabbiani M, Pierotti P, Donato F, Quiros-Roldan E; MASTER Cohort.

BMC Public Health. 2015 Mar 12;15:235. doi: 10.1186/s12889-015-1565-0.

13.

Spectrum of cancer risk late after AIDS onset in the United States.

Simard EP, Pfeiffer RM, Engels EA.

Arch Intern Med. 2010 Aug 9;170(15):1337-45. doi: 10.1001/archinternmed.2010.253.

14.

[Malignancy cases in HIV-positive patients in Lodz region in years 1992-2010].

Jabłonowska E, Małolepsza E, Strycharz M, Wójcik K.

Przegl Epidemiol. 2011;65(2):339-43. Polish.

PMID:
21913486
15.

Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons.

Chao C, Leyden WA, Xu L, Horberg MA, Klein D, Towner WJ, Quesenberry CP Jr, Abrams DI, Silverberg MJ.

AIDS. 2012 Nov 13;26(17):2223-31. doi: 10.1097/QAD.0b013e32835935b3.

16.

Long-term cancer risk among people diagnosed with AIDS during childhood.

Simard EP, Shiels MS, Bhatia K, Engels EA.

Cancer Epidemiol Biomarkers Prev. 2012 Jan;21(1):148-54. doi: 10.1158/1055-9965.EPI-11-0823. Epub 2011 Nov 8.

17.

HIV infection and the risk of cancers with and without a known infectious cause.

Silverberg MJ, Chao C, Leyden WA, Xu L, Tang B, Horberg MA, Klein D, Quesenberry CP Jr, Towner WJ, Abrams DI.

AIDS. 2009 Nov 13;23(17):2337-45. doi: 10.1097/QAD.0b013e3283319184.

18.

Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals.

Long JL, Engels EA, Moore RD, Gebo KA.

AIDS. 2008 Feb 19;22(4):489-96. doi: 10.1097/QAD.0b013e3282f47082.

19.

Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007.

Seaberg EC, Wiley D, Martínez-Maza O, Chmiel JS, Kingsley L, Tang Y, Margolick JB, Jacobson LP; Multicenter AIDS Cohort Study (MACS).

Cancer. 2010 Dec 1;116(23):5507-16. doi: 10.1002/cncr.25530. Epub 2010 Jul 29.

20.

Cancer burden in the HIV-infected population in the United States.

Shiels MS, Pfeiffer RM, Gail MH, Hall HI, Li J, Chaturvedi AK, Bhatia K, Uldrick TS, Yarchoan R, Goedert JJ, Engels EA.

J Natl Cancer Inst. 2011 May 4;103(9):753-62. doi: 10.1093/jnci/djr076. Epub 2011 Apr 11.

Supplemental Content

Support Center